Codexis Inc. (CDXS)

8.97
0.07 0.83
NASDAQ : Process Industries
Prev Close 9.05
Open 9.10
Day Low/High 8.85 / 9.22
52 Wk Low/High 3.60 / 9.45
Volume 188.17K
Avg Volume 239.30K
Exchange NASDAQ
Shares Outstanding 48.35M
Market Cap 452.04M
EPS -0.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Codexis Reaches Analyst Target Price

In recent trading, shares of Codexis Inc have crossed above the average analyst 12-month target price of $8.50, changing hands for $8.80/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Tough Day for Apple and Airlines

Price action isn't a sign of bearishness.

Codexis Reaches Analyst Target Price

In recent trading, shares of Codexis Inc have crossed above the average analyst 12-month target price of $7.38, changing hands for $7.85/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Codexis Obtains Court Order Awarding Summary Judgment Of Patent Infringement Against EnzymeWorks

Codexis Obtains Court Order Awarding Summary Judgment Of Patent Infringement Against EnzymeWorks

Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, on Tuesday secured a federal court order awarding it summary judgment on 10 claims of patent infringement it brought in a lawsuit against Suzhou,...

Codexis Signs Second Multi-Year Agreement In Food Industry With Tate & Lyle

Codexis to Research and Develop Novel Enzymes Supporting Tate & Lyle's Food Ingredient Growth Strategies

TheStreet Quant Rating: D (Sell)